pharmaphorum7 年
GSK and Propeller prepare to launch digital inhaler
GlaxoSmithKline and Propeller Health's partnership to develop digital solutions for asthma and chronic obstructive pulmonary disorder (COPD) is expanding into a commercialisation deal. Having ...
pharmaphorum6 年
FDA approves expanded use for GSK's COPD triple therapy
The FDA has approved an expanded label for GlaxoSmithKline’s new Trelegy Ellipta inhaler, allowing it to ... s already approved combinations Relvar/Breo Ellipta and Anoro Ellipta.